A pharmacovigilance study of adverse events associated with polymyxins based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database
Article in Expert Opinion on Drug Safety (May 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses
Article in mBio (February 2024)
Peptide-mimicking poly(2-oxazoline)s as adjuvants to enhance activities and antibacterial spectrum of polymyxin B
Article in Science China Materials (January 2024)